Barclays Retains an Equal Weight Rating on Acadia Healthcare Company, Inc. (ACHC)

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) is among the 12 Best Performing Stocks in February.

On March 2, 2026, Barclays analyst Andrew Mok elevated Acadia Healthcare Company, Inc. (NASDAQ:ACHC)'s price goal to $20 from $14, maintaining an Equal Weight rating.

On February 25, 2026, Acadia Healthcare Company, Inc. (NASDAQ:ACHC) announced fourth-quarter 2025 revenue of $821.5 million, a 6.1% gain over the previous year. Same-facility revenue climbed 4.4%, driven by a 3.1% increase in patient days and a 1.3% rise in revenue per day. The firm reported a net loss of $13.02 per diluted share, which included a $996.2 million non-cash goodwill impairment charge, while adjusted net income was $6.1 million, or $0.07 per share. Adjusted EBITDA was $99.8 million, with a $52.7 million adjustment to professional and general liability reserves. CEO Debbie Osteen stated that the quarter saw solid volume growth. The corporation increased licensed beds by 181 in the quarter and by 1,089 in 2025, with revenue expected to range from $3.37 to $3.45 billion in 2026. The adjusted EPS projection ranges from $1.30 to $1.55.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) provides behavioral healthcare services in the United States. The firm serves its patients in several settings, including inpatient mental hospitals, specialty treatment facilities, residential treatment programs, and outpatient clinics.

While we acknowledge the potential of ACHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the

.

: and .